A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the ...

The maximum dosage of Zepbound is 15 mg injected once per week. The recommended maintenance dosage for adults with obstructive sleep apnea is 10 mg or 15 mg injected once per week. Your doctor ...

The company is now offering 7.5 mg and 10 mg vials, higher doses than it's offered since launching Zepbound vials in August. It’s also slashing the cost of 2 mg and 5 mg vials by $50 a month.

For OSA, the maintenance dosage will likely be 10 mg or 15 mg injected once per week. The maximum dosage of Zepbound for either of its uses is 15 mg injected once per week. »Get more information ...

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

The cost for Zepbound vials starts at $349 per month for the 2.5 mg dose, rising to $499 for the higher 5, 7.5, and 10 mg doses. To access this pricing, your doctor must send a prescription for th ...

The approval was based on results from the SURMOUNT-OSA phase 3 clinical trials, which evaluated Zepbound (10 mg or 15 mg) for the treatment of moderate-to-severe OSA in adults with obesity ...

Our analyst team just revealed what they believe are the 10 best stocks to buy right now ... Last quarter alone, its two leading GLP-1 drugs, Mounjaro and Zepbound, generated a combined $5.4 billion ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.